2C-T-19

2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.

In his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.

As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.

In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.